Total Artificial Heart Market

Total Artificial Heart Market Overview (2022-2032)

The global total artificial heart market was valued at around US$ 191.1Mn in 2021, registering Y-o-Y growth of 13.8%. Total artificial heart market sales are projected to increase at a healthy CAGR of 12.2% by 2032.

“The upsurge in the cardiac diseases among the population and developing healthcare infrastructure in the developing countries is anticipated to boost the market for the total artificial heart.”

Attributes	Details
Total Artificial Heart Market Value in 2021	US$ 191.9 Million
Total Artificial Heart Market Value in 2022	US$ 218.3 Million
Total Artificial Heart Market CAGR (2022 to 2032)	12.2%

A pump that is surgically placed while performing cardiac surgery is referred to as a total artificial heart. A total artificial heart is designed to provide circulation and swap cardiac ventricles. Blood is pumped from the ventricles of the heart to the lungs and other organs. The implanted pumps are managed by machines outside the body, assisting blood flow to and from the heart.

The total artificial heart works by replacing the lower chambers of the heart, known as the ventricles. The total artificial heart is connected with tubes to a power source that is out of the human body. Through the heart’s major artery, the total artificial heart then pumps blood to the lungs and the rest of the body.

The total artificial heart consists of four mechanical valves that operate like the real valves of the heart and has a vital role to maintain the blood flow. The arteries, the atrium, the aorta, and the pulmonary artery are connected to the total artificial heart with the help of these valves.

As it is connected to the right and the left atria of the heart, the functioning of a normal heart is duplicated, providing circulatory support and restoring normal blood flow across the body. After this, the total artificial heart is activated.

What are the Major Drivers Boosting the Demand for Total Artificial Heart Market?

The primary factor driving the market growth of total artificial heart is the increasing prevalence of cardiac disorders, along with the rising healthcare awareness among the population. Additionally, rising rates of heart failure and increasing old age population are driving the growth in the market revenue.

Besides these factors, an increase in the number of hospitals and specialty centers, increased healthcare expenditure, and adoption of poor lifestyle habits are predicted to increase the growth of the total artificial heart market.

Furthermore, the introduction of various programs for spreading awareness among the population, and increasing government initiatives for the treatment of cardiac disorders are anticipated to increase the growth of the total artificial heart.

Which Region Shows Strong Growth Potential in the Total Artificial Heart Market?

North America’s total artificial heart market is expected to dominate the global market in projected years, owing to the establishment of a large number of research centers and well-developed healthcare infrastructure in this region.

Following North America, Europe is also predicted to hold a lucrative share in the total artificial heart market because of the rising prevalence of cardiac disorders. The market in East and South Asian countries like China and India is also expected to show a sustainable growth rate in near future owing to an increasing rate of heart surgeries.

Who are the Key Manufacturers of the Total Artificial Heart Market?

Some of the key manufacturers operating in the total artificial heart market are BiVACOR Inc., CARMAT, SynCardia Systems, LLC, ReinHeart TAH GmbH, ABIOMED, Abbott, Cirtec, LivaNova, Inc., Jarvik Heart, Inc., and CryoLife, Inc.

Report scope

Attributes	Details
Forecast Period	2022 to 2032
Historical Data Available for	2012 to 2021
Market Analysis	US$ Million for Value
By Product Type	SynCardia Systems BiVACOR Rotary Total Artificial Heart CARMAT Others
By End User	Hospitals Specialty Centers Others
By Region	North America Latin America Europe East Asia South Asia Oceania Middle East & Africa
Key Players	BiVACOR Inc. CARMAT SynCardia Systems, LLC ReinHeart TAH GmbH ABIOMED Abbott Cirtec LivaNova, Inc. Jarvik Heart, Inc. CryoLife, Inc.

Key Segmentation

By Product Type:

• SynCardia Systems
• BiVACOR Rotary Total Artificial Heart
• CARMAT
• Others

By End User:

• Hospitals
• Specialty Centers
• Others

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa